Sintecabio has ranked among the top searched stocks on 9 days within the past month.


As of 1:33 PM on the 5th, Sintecabio is trading at 45,050 KRW, up 15.81% from the previous day. This marks a 210.69% increase compared to September 2. Sintecabio is known as a genomic big data research company.

Today, foreigners are tentatively recorded as net sellers of 9,000 shares. Over the past 5 days, individual investors have net bought 57,640 shares, while foreigners and institutions have net sold 59,425 shares and net bought 2,690 shares, respectively.


On September 29, Sintecabio became a market issue with the headline "COVID-19 treatment efficacy Remdesivir doubled, hitting the upper price limit."





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing